{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T10:54:42Z","timestamp":1791370482473,"version":"4.3.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"DOI":"10.1007\/s40121-026-01454-w","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T10:34:33Z","timestamp":1791369273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Invasive Pneumococcal Disease in Children: A Retrospective Three-Center Study in Zhejiang Province, China (2010\u20132024)"],"prefix":"10.1007","author":[{"given":"Yan-Yan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Si","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Hu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Catusse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen M.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2829-5878","authenticated-orcid":false,"given":"Chun-Zhen","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"issue":"9693","key":"1454_CR1","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","volume":"374","author":"KL O'Brien","year":"2009","unstructured":"O\u2019Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374(9693):893\u2013902. https:\/\/doi.org\/10.1016\/S0140-6736(09)61204-6.","journal-title":"Lancet"},{"issue":"1","key":"1454_CR2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/21645515.2017.1371378","volume":"14","author":"M Ceyhan","year":"2018","unstructured":"Ceyhan M, Ozsurekci Y, Aykac K, et al. Economic burden of pneumococcal infections in children under 5 years of age. Hum Vaccin Immunother. 2018;14(1):106\u201310. https:\/\/doi.org\/10.1080\/21645515.2017.1371378.","journal-title":"Hum Vaccin Immunother"},{"key":"1454_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1147-x","volume":"15","author":"M Tin Tin Htar","year":"2015","unstructured":"Tin Tin Htar M, Christopoulou D, Schmitt HJ. Pneumococcal serotype evolution in Western Europe. BMC Infect Dis. 2015;15:419. https:\/\/doi.org\/10.1186\/s12879-015-1147-x.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1454_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-018-0607-z","volume":"20","author":"N Principi","year":"2018","unstructured":"Principi N, Di Cara G, Bizzarri I, et al. Prevention of invasive pneumococcal disease: problems emerged after some years of the 13-valent pneumococcal conjugate vaccine use. Curr Infect Dis Rep. 2018;20(1):1. https:\/\/doi.org\/10.1007\/s11908-018-0607-z.","journal-title":"Curr Infect Dis Rep"},{"issue":"34","key":"1454_CR5","doi-asserted-by":"publisher","first-page":"5454","DOI":"10.1016\/j.vaccine.2020.06.040","volume":"38","author":"L Siira","year":"2004","unstructured":"Siira L, Vestrheim DF, Winje BA, et al. Antimicrobial susceptibility and clonality of Streptococcus pneumoniae isolates recovered from invasive disease cases during a period with changes in pneumococcal childhood vaccination, Norway, 2004-2016. Vaccine. 2004;38(34):5454\u201363. https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.040.","journal-title":"Vaccine"},{"issue":"3","key":"1454_CR6","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00937-20","volume":"11","author":"F Ganaie","year":"2020","unstructured":"Ganaie F, Saad JS, McGee L, et al. A new pneumococcal capsule type, 10D, is the 100th serotype and has a large cps fragment from an oral streptococcus. MBio. 2020;11(3):e00937-20. https:\/\/doi.org\/10.1128\/mBio.00937-20.","journal-title":"MBio"},{"issue":"4","key":"1454_CR7","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1093\/infdis\/jiaf376","volume":"232","author":"LM King","year":"2025","unstructured":"King LM, Andrejko KL, Kobayashi M, et al. Pneumococcal serotype distribution and coverage of existing and pipeline pneumococcal vaccines. J Infect Dis. 2025;232(4):e609\u201320. https:\/\/doi.org\/10.1093\/infdis\/jiaf376.","journal-title":"J Infect Dis"},{"issue":"4","key":"1454_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S1473-3099(24)00665-0","volume":"25","author":"JC Bennett","year":"2025","unstructured":"Bennett JC, Deloria Knoll M, Kagucia EW, et al. Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis. Lancet Infect Dis. 2025;25(4):457\u201370. https:\/\/doi.org\/10.1016\/S1473-3099(24)00665-0.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"1454_CR9","doi-asserted-by":"publisher","first-page":"e1062","DOI":"10.1093\/cid\/ciac475","volume":"76","author":"LR Grant","year":"2023","unstructured":"Grant LR, Slack MP, Theilacker C, et al. Distribution of serotypes causing invasive pneumococcal disease in children from high-income countries and the impact of pediatric pneumococcal vaccination. Clin Infect Dis. 2023;76(3):e1062\u201370. https:\/\/doi.org\/10.1093\/cid\/ciac475.","journal-title":"Clin Infect Dis"},{"issue":"17","key":"1454_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.46234\/ccdcw2023.072","volume":"5","author":"L Liu","year":"2019","unstructured":"Liu L, Zhang Z, Zhang X, et al. Coverage of 13-valent pneumococcal conjugate vaccine among children 0-15 months of age\u20149 provinces, China, 2019-2021. China CDC Wkly. 2019;5(17):379\u201384. https:\/\/doi.org\/10.46234\/ccdcw2023.072.","journal-title":"China CDC Wkly"},{"issue":"1","key":"1454_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-019-1722-1","volume":"19","author":"J Fu","year":"2019","unstructured":"Fu J, Yi R, Jiang Y, et al. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae causing invasive diseases in China: a meta-analysis. BMC Pediatr. 2019;19(1):424. https:\/\/doi.org\/10.1186\/s12887-019-1722-1.","journal-title":"BMC Pediatr"},{"issue":"1","key":"1454_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2332670","volume":"13","author":"X Ning","year":"2019","unstructured":"Ning X, Li L, Liu J, et al. Invasive pneumococcal diseases in Chinese children: a multicentre hospital-based active surveillance from 2019 to 2021. Emerg Microbes Infect. 2019;13(1):2332670. https:\/\/doi.org\/10.1080\/22221751.2024.2332670.","journal-title":"Emerg Microbes Infect"},{"key":"1454_CR13","doi-asserted-by":"publisher","first-page":"1337276","DOI":"10.3389\/fpubh.2024.1337276","volume":"12","author":"MM Sandoval","year":"2024","unstructured":"Sandoval MM, Ruvinsky S, Palermo MC, et al. Antimicrobial resistance of Streptococcus pneumoniae from invasive pneumococcal diseases in Latin American countries: a systematic review and meta-analysis. Front Public Health. 2024;12:1337276. https:\/\/doi.org\/10.3389\/fpubh.2024.1337276.","journal-title":"Front Public Health"},{"issue":"2","key":"1454_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jmii.2021.05.008","volume":"55","author":"YT Tsai","year":"2017","unstructured":"Tsai YT, Lee YL, Lu MC, et al. Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019. J Microbiol Immunol Infect. 2017;55(2):215\u201324. https:\/\/doi.org\/10.1016\/j.jmii.2021.05.008.","journal-title":"J Microbiol Immunol Infect"},{"key":"1454_CR15","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing. 34th ed. CLSI supplement M100. 2024. https:\/\/clsi.org\/shop\/standards\/m100\/"},{"issue":"8","key":"1454_CR16","first-page":"85","volume":"94","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper-February 2019. Wkly Epidemiol Rec. 2019;94(8):85\u2013104.","journal-title":"Wkly Epidemiol Rec."},{"issue":"12","key":"1454_CR17","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3760\/cma.j.issn.0578-1310.2018.12.006","volume":"56","author":"L Zhu","year":"2018","unstructured":"Zhu L, Li WH, Wang XH, et al. A multicenter clinical study on 1,138 cases of invasive pneumococcal disease in children from 2012 to 2017. Zhonghua Er Ke Za Zhi. 2018;56(12):915\u201322. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1310.2018.12.006.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"8","key":"1454_CR18","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3760\/cma.j.cn101070-20190821-00777","volume":"35","author":"QY Li","year":"2020","unstructured":"Li QY, Li YY, Yi Q, et al. Clinical characteristics and antibiotic sensitivity in children with invasive pneumococcal disease. Chin J Appl Clin Pediatr. 2020;35(8):586\u20139. https:\/\/doi.org\/10.3760\/cma.j.cn101070-20190821-00777.","journal-title":"Chin J Appl Clin Pediatr."},{"issue":"8","key":"1454_CR19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3760\/cma.j.cn101070-20200106-00021","volume":"35","author":"K Tan","year":"2020","unstructured":"Tan K, Wang HM, Bao YM, et al. Clinical characteristics, antimicrobial resistance and serotype analysis of children\u2019s invasive pneumococcal disease in Shenzhen. Chin J Appl Clin Pediatr. 2020;35(8):561\u20135. https:\/\/doi.org\/10.3760\/cma.j.cn101070-20200106-00021.","journal-title":"Chin J Appl Clin Pediatr"},{"issue":"12","key":"1454_CR20","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3760\/cma.j.issn.1673-4912.2018.12.011","volume":"25","author":"Z Xu","year":"2018","unstructured":"Xu Z, Zhang J, Han ML, et al. Analysis of serotype and clinical manifestation of 80 children with invasive pneumococcal disease in Suzhou. Chin Pediatr Emerg Med. 2018;25(12):933\u20138. https:\/\/doi.org\/10.3760\/cma.j.issn.1673-4912.2018.12.011.","journal-title":"Chin Pediatr Emerg Med"},{"key":"1454_CR21","unstructured":"U.S. Centers for Disease Control and Prevention. Active bacterial core surveillance (ABCs) report: emerging infections program network Streptococcus pneumoniae, 2023 [2025-3-20]. https:\/\/www.cdc.gov\/abcs\/downloads\/SPN_Surveillance_Report_2023.pdf"},{"issue":"7","key":"1454_CR22","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.vaccine.2019.12.038","volume":"38","author":"EN Berezin","year":"2020","unstructured":"Berezin EN, Jarovsky D, Cardoso MRA, et al. Invasive pneumococcal disease among hospitalized children in Brazil before and after the introduction of a pneumococcal conjugate vaccine. Vaccine. 2020;38(7):1740\u20135. https:\/\/doi.org\/10.1016\/j.vaccine.2019.12.038.","journal-title":"Vaccine"},{"issue":"1","key":"1454_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/INF.0000000000003748","volume":"42","author":"JV Warmerdam","year":"2023","unstructured":"Warmerdam JV, Campigotto A, Bitnun A, et al. Invasive pneumococcal disease in high-risk children: a 10-year retrospective study. Pediatr Infect Dis J. 2023;42(1):74\u201381. https:\/\/doi.org\/10.1097\/INF.0000000000003748.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"1454_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/INF.0000000000002489","volume":"39","author":"H Hernstadt","year":"2020","unstructured":"Hernstadt H, Cheung A, Hurem D, et al. Changing epidemiology and predisposing factors for invasive pneumococcal disease at two Australian tertiary hospitals. Pediatr Infect Dis J. 2020;39(1):1\u20136. https:\/\/doi.org\/10.1097\/INF.0000000000002489.","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"1454_CR25","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/jamapediatrics.2019.3203","volume":"173","author":"C Butters","year":"2019","unstructured":"Butters C, Phuong LK, Cole T, et al. Prevalence of immunodeficiency in children with invasive pneumococcal disease in the pneumococcal vaccine era: a systematic review. JAMA Pediatr. 2019;173(11):1084\u201394. https:\/\/doi.org\/10.1001\/jamapediatrics.2019.3203.","journal-title":"JAMA Pediatr"},{"issue":"3","key":"1454_CR26","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-0567","volume":"144","author":"SL Kaplan","year":"2014","unstructured":"Kaplan SL, Barson WJ, Lin PL, et al. Invasive pneumococcal disease in children\u2019s hospitals: 2014-2017. Pediatrics. 2014;144(3):e20190567. https:\/\/doi.org\/10.1542\/peds.2019-0567.","journal-title":"Pediatrics"},{"issue":"5","key":"1454_CR27","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s40121-023-00798-x","volume":"12","author":"J Perdrizet","year":"2023","unstructured":"Perdrizet J, Horn EK, Hayford K, et al. Historical population-level impact of infant 13-valent pneumococcal conjugate vaccine (PCV13) national immunization programs on invasive pneumococcal disease in Australia, Canada, England and Wales, Israel, and the United States. Infect Dis Ther. 2023;12(5):1351\u201364. https:\/\/doi.org\/10.1007\/s40121-023-00798-x.","journal-title":"Infect Dis Ther"},{"issue":"26","key":"1454_CR28","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1056\/NEJM200012283432603","volume":"343","author":"CG Whitney","year":"2000","unstructured":"Whitney CG, Farley MM, Hadler J, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med. 2000;343(26):1917\u201324. https:\/\/doi.org\/10.1056\/NEJM200012283432603.","journal-title":"N Engl J Med"},{"key":"1454_CR29","unstructured":"U.S. Centers for Disease Control and Prevention. Active bacterial core surveillance (ABCs) report: emerging infections program network Streptococcus pneumoniae, 2023. https:\/\/www.cdc.gov\/abcs\/bact-facts\/data-dashboard.html"},{"issue":"52","key":"1454_CR30","doi-asserted-by":"publisher","first-page":"7545","DOI":"10.1016\/j.vaccine.2021.11.032","volume":"39","author":"S Nasreen","year":"2002","unstructured":"Nasreen S, Wang J, Kwong JC, et al. Population-based incidence of invasive pneumococcal disease in children and adults in Ontario and British Columbia, 2002-2018: a Canadian Immunization Research Network (CIRN) study. Vaccine. 2002;39(52):7545\u201353. https:\/\/doi.org\/10.1016\/j.vaccine.2021.11.032.","journal-title":"Vaccine"},{"issue":"4","key":"1454_CR31","doi-asserted-by":"publisher","first-page":"505","DOI":"10.33321\/cdi.2002.26.48","volume":"26","author":"P Roche","year":"2002","unstructured":"Roche P, Krause V. Invasive pneumococcal disease in Australia, 2001. Commun Dis Intell Q Rep. 2002;26(4):505\u201319. https:\/\/doi.org\/10.33321\/cdi.2002.26.48.","journal-title":"Commun Dis Intell Q Rep"},{"key":"1454_CR32","unstructured":"Public Health Agency of Canada. Invasive pneumococcal disease in Canada: annual surveillance report, 2024. https:\/\/publications.gc.ca\/collections\/collection_2024\/aspc-phac\/HP5-239-1-2024-eng.pdf"},{"issue":"1","key":"1454_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.vaccine.2022.11.006","volume":"41","author":"N Homaira","year":"2023","unstructured":"Homaira N, Strachan R, Quinn H, et al. Real world impact of 13vPCV in preventing invasive pneumococcal pneumonia in Australian children: a national study. Vaccine. 2023;41(1):85\u201391. https:\/\/doi.org\/10.1016\/j.vaccine.2022.11.006.","journal-title":"Vaccine"},{"key":"1454_CR34","doi-asserted-by":"publisher","first-page":"798750","DOI":"10.3389\/fmicb.2021.798750","volume":"12","author":"ML Zhou","year":"2022","unstructured":"Zhou ML, Wang ZR, Zhang L, et al. Serotype distribution, antimicrobial susceptibility, multilocus sequencing type and virulence of invasive Streptococcus pneumoniae in China: a six-year multicenter study. Front Microbiol. 2022;12:798750. https:\/\/doi.org\/10.3389\/fmicb.2021.798750.","journal-title":"Front Microbiol"},{"key":"1454_CR35","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.2147\/IDR.S454042","volume":"17","author":"X Huo","year":"2024","unstructured":"Huo X, Tan Z, Qian H, et al. Serotypes and genotypes of Streptococcus pneumoniae in an unvaccinated population in Suzhou, China. Infect Drug Resist. 2024;17:4001\u20139.","journal-title":"Infect Drug Resist."},{"key":"1454_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1184059","volume":"11","author":"XR Che","year":"2017","unstructured":"Che XR, Chen QH, Liu Y, et al. Analysis of 13-valent pneumococcal polysaccharide conjugate vaccine among children born in Hangzhou from 2017 to 2021. Front Public Health. 2017;11:1184059. https:\/\/doi.org\/10.3389\/fpubh.2023.1184059.","journal-title":"Front Public Health"},{"key":"1454_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2026.108584","volume":"167","author":"Y Liu","year":"2026","unstructured":"Liu Y, Lu ZJ, Yang JH, et al. Effectiveness of 13-valent pneumococcal conjugate vaccine against vaccine-type invasive pneumococcal disease in children under 5 Years Old in Zhejiang, China: a case-control study. Int J Infect Dis. 2026;167:108584. https:\/\/doi.org\/10.1016\/j.ijid.2026.108584.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"1454_CR38","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2573542","volume":"21","author":"R Peng","year":"2025","unstructured":"Peng R, Zhang T, Dunne EM, et al. Effectiveness and impact of 7 and 13-valent pneumococcal conjugate vaccines in Chinese children: a systematic review and meta-analysis. Hum Vaccin Immunother. 2025;21(1):2573542. https:\/\/doi.org\/10.1080\/21645515.2025.2573542.","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"1454_CR39","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3760\/cma.j.issn.0578-1310.2018.08.005","volume":"56","author":"C Fang","year":"2018","unstructured":"Fang C, Chen XJ, Zhou MM, et al. Clinical characteristics and antimicrobial resistance of pneumococcal infections from 9 children\u2019s hospitals in 2016. Zhonghua Er Ke Za Zhi. 2018;56(8):582\u20136. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1310.2018.08.005.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"1","key":"1454_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.16718\/j.1009-7708.2020.01.001","volume":"20","author":"FP Hu","year":"2020","unstructured":"Hu FP, Guo Y, Zhu DM, et al. CHINET surveillance of bacterial resistance in China: 2018 report. Chin J Infect Chemother. 2020;20(1):1\u201310. https:\/\/doi.org\/10.16718\/j.1009-7708.2020.01.001.","journal-title":"Chin J Infect Chemother"},{"issue":"5","key":"1454_CR41","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3760\/cma.j.issn.0578-1310.2019.05.008","volume":"57","author":"CY Wang","year":"2019","unstructured":"Wang CY, Xu HM, Deng JK, et al. A multicentric clinical study on clinical characteristics and drug sensitivity of children with pneumococcal meningitis in China. Zhonghua Er Ke Za Zhi. 2019;57(5):355\u201362. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1310.2019.05.008.","journal-title":"Zhonghua Er Ke Za Zhi"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01454-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-026-01454-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01454-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T10:34:41Z","timestamp":1791369281000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-026-01454-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":41,"alternative-id":["1454"],"URL":"https:\/\/doi.org\/10.1007\/s40121-026-01454-w","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An-Li Sun, Julie Catusse and Eileen M. Dunne are employed by Pfizer and may hold stock or stock options. Yan-Yan Zhu, Jin-Si Zhou, Jin-Hong Yang, Zhao-Jun Lu, Chao Fang, Ming-Ming Zhou, Kai-Hu Yao, Xiao-Yu Li and Chun-Zhen Hua have no conflicts of interest to declare.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Children's Hospital, Zhejiang University School of Medicine (No.: 2021 - IRB - 141 - A1), the Ethics Committee of Hangzhou Children's Hospital (No.:2021(78), and the Ethics Committee of Yuying Children\u2019s Hospital of Wenzhou Medical University (No.: 2023-K-194-02). The study was performed in accordance with the Helsinki Declaration of 1964, and its later amendments. Informed consent was not required as study data were anonymized and no study-specific procedures were performed. Data including age, gender, date of disease, underlying diseases, infection site, complications, treatments, and outcomes were extracted from medical records.","order":2,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}